Clinical trials in Abbeville

Innovative trials exploring treatment options for non-small cell lung cancer and small cell lung cancer, focusing on immunotherapy combinations and targeted therapies.

• Immunotherapy evaluation
• Treatment optimization for elderly patients
• Novel therapy combinations

Studies examining the effectiveness of various treatment durations and combinations for advanced-stage lung cancers.

Research focusing on multiple myeloma treatment strategies, including studies of innovative drug combinations and therapy duration optimization.

• Treatment duration assessment
• Drug combination efficacy
• Relapsed disease management

Investigations into optimizing treatment approaches for blood-based cancers.

Clinical trials examining treatments for Mycobacterium infections, including innovative approaches to pulmonary infections.

• Antibiotic therapy comparison
• Pulmonary infection management
• Treatment optimization protocols

Evaluating new treatment methods for complex bacterial infections.

Studies focused on colon carcinoma and hepatocellular carcinoma, investigating novel treatment approaches.

• Neoadjuvant therapy assessment
• Elderly patient care
• Immunotherapy combinations

Exploring innovative treatment strategies for gastrointestinal cancers.

Research investigating treatments for septic shock and related complications, including innovative supplementation approaches.

• Kidney protection strategies
• Vitamin supplementation studies
• Critical care outcomes

Evaluating new approaches to prevent complications in critically ill patients.